NCT02200042
Gemcitabine Hydrochloride and Cisplatin With or Without Radiation Therapy in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
1959 NE Pacific Street
Seattle, WA 98195
206.598.4100
1354 Aloha Street
Seattle, WA 98109
206.606.7318
1570 N 115th Street
Seattle, WA 98133
http://www.sccaprotontherapy.com/ 206.306.2800
Dr. Apisarnthanarax is a radiation oncologist with expertise in gastrointestinal cancers and genitourinary tumors, including prostate cancer. He also specializes in proton therapy, stereotactic body radiation therapy, and liver cancer.
“Being diagnosed with and treated for cancer is one of the most arduous journeys that any person will experience. Every patient and every cancer is different. As a radiation oncologist, my goal is to guide patients through this difficult time by providing the most compassionate, personalized care possible and making sure they have access to the latest, innovative clinical trials and state-of-art technology.”
College: Brown University, Providence, RI, 1998
Medical Education: Brown University Warren Alpert Medical School, Providence, RI, 2002
Internship: Northwestern University – Evanston Hospital, Evanston, IL, 2003
Fellowship: Experimental Radiation Oncology, M.D. Anderson Cancer Center, Houston, TX, 2005
Residency: Radiation Oncology, University of North Carolina, Chapel Hill, NC, 2009
Gemcitabine Hydrochloride and Cisplatin With or Without Radiation Therapy in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD